Articles tagged with Medical Treatments
A cohort study found that stroke center certification decreases racial disparities in treatment for white patients within the same hospital, but such disparities remain for Black patients. This suggests continued systemic inequalities in stroke care settings.
This book presents cutting-edge approaches to combat cancer, including exosomal delivery systems, CRISPR/Cas9 gene editing, and immunotoxin therapy. Natural compounds are also examined for their anticancer potential.
A new study shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV. The treatment uses an adeno-associated virus to deliver instructions to muscle cells, which produce broadly neutralizing antibodies capable of neutralizing multiple strains of HIV.
Researchers found that vitamin D supplementation reduces liver inflammation and fibrosis in patients with chronic liver disease by upregulating the TXNIP gene in ductular cells. The study provides new insights into the underlying mechanisms of liver diseases and offers a potential therapeutic target for improving outcomes.
Patients with type 2 diabetes experience more severe financial difficulties compared to those without the condition. The study emphasizes the importance of considering patient financial health when treating type 2 diabetes, particularly for vulnerable populations.
A study by researchers at UCSF found that young patients who received eight or more outpatient therapy sessions after a hospital stay were 25 times less likely to be readmitted. The therapy was delivered by community-based clinicians and did not require specialist expertise. This simple yet effective approach has the potential to break...
Researchers at the University of Vienna have discovered a new mechanism for triggering mitophagy, a self-cleaning process in cells crucial for health. The study reveals that NIX and BNIP3 can trigger autophagy without binding to FIP200, suggesting alternative molecular strategies depending on the receptor and context.
A recent study by JAMA Network Open reveals racial differences in care quality among men with newly diagnosed prostate cancer. Black men had lower odds of overtreatment, suggesting better care, while having lower odds of confirmatory testing on active surveillance, indicating worse care.
Researchers at Fralin Biomedical Research Institute have identified a potential target for experimental drugs that block PRMT5, a naturally occurring enzyme some tumors rely on for survival. The study found a new drug combination that works against certain hard-to-treat cancers.
Remote, scalable cognitive behavioral therapy-based treatments improved pain and quality-of-life outcomes for individuals with high-impact chronic pain. These lower-resource treatments could increase availability of evidence-based nonpharmacologic pain treatments.
A new breath test has been developed to detect blood cancers, showing promise for early diagnosis and treatment monitoring. The test uses exhaled breath analysis to identify molecules produced by cancer cells, potentially providing a quick and affordable diagnostic tool for areas with limited access to specialist equipment.
Researchers at MURR have optimized Terbium-161 for radiopharmaceutical use, enabling targeted destruction of cancer cells with high-energy electrons. The breakthrough could add extra therapeutic effectiveness to existing treatments without requiring new drug development.
A new study published in JAMA Network Open found no statistical relationship between pathologic complete response (pCR) and overall survival in rectal cancer patients. This challenges the FDA's use of pCR as a surrogate endpoint for drug approval, which may lead to treatments being fast-tracked without evidence of improved long-term su...
Researchers have discovered a key role of centrosomes in signaling cells to proliferate despite DNA damage, enabling cancer resistance. The study suggests targeting Polo-like kinase 1 could prevent adaptation to therapy-induced DNA damage and drug resistance.
ADLM 2025 will tackle urgent topics like clinical AI integration and fake medical news, as well as leveraging genomics for personalized healthcare. The meeting also explores the health threat of plastics and microbiome medicine to combat diseases.
A study on public perception of physicians who use AI found that while effects are relatively small, they may be highly relevant due to the close link between trust in healthcare practitioners and subjective treatment outcomes. The integration of AI in healthcare has sparked certain reservations among the public.
Scientists have discovered that microglia play a crucial role in regulating blood flow to the brain, and targeting them may improve blood flow deficits. The study suggests that restoring microglia function could prevent or reverse memory-stealing diseases caused by lack of adequate blood flow.
A new music therapy approach called MELODIC showed promising results in reducing distress symptoms and improving quality-of-life scores among dementia patients. The intervention, which costs £2,025 per month, could provide a low-cost and scalable alternative to current methods of managing severe distress.
The Be Well Texas initiative, led by the University of Texas Health Science Center at San Antonio, will expand access to opioid use disorder treatment services and recovery support across rural and urban communities. This major statewide expansion aims to reduce overdose deaths and build a lasting recovery infrastructure.
Research suggests that linear amplification can improve vocal emotion recognition in individuals with mild-to-moderate sensorineural hearing loss. The study found that amplification across all sound levels can enhance the ability to recognize emotions in voices, particularly in middle-aged and older adults.
Researchers successfully treated a patient with a rare IDH2-mutant brainstem astrocytoma using temozolomide and radiation, resulting in significant tumor shrinkage and improved hearing. The patient's unique genetic profile was identified through magnetic resonance spectroscopy and surgical biopsy, allowing for targeted treatment.
A new treatment approach using cyclophosphamide has been found to prevent most graft-versus-host disease in mismatched transplants. The study shows that 80% of patients are alive after a year, similar to outcomes seen in fully matched transplants.
Delays in hypertension diagnosis were common, associated with delayed treatment initiation and adverse cardiovascular outcomes. The study highlights the need for earlier identification and intervention to improve treatment and patient outcomes.
A study of 62,839 people diagnosed with non-metastatic prostate cancer in Sweden found that those treated according to NCCN Guidelines were likely to survive their cancer for their remaining life-expectancy. Those with low- and intermediate-risk cancer were six times more likely to die of other causes than prostate cancer.
In a small clinical study, users of this prosthesis navigated more easily and said the limb felt more like part of their body. The new system is directly integrated with the user’s muscle and bone tissue, enabling greater stability and control.
A new study found that a nontargeted screening approach can identify more patients with hepatitis C virus infections than traditional targeted screening methods. The results highlight the need for improved treatment models, as patients who went from diagnosis to sustained virologic response increased significantly.
Artificial intelligence (AI) is revolutionizing medical needle procedures by providing unprecedented levels of accuracy and precision. AI-powered robots can assist physicians in complex tasks, enabling safer and more effective procedures. The four components of AI guidance are formalized, categorizing current systems into Eyes-on/Hands...
A novel nanocarrier system utilizing metal-polyphenols enables precise intracellular delivery of therapeutic antibodies into cancer cells. This technology overcomes endosomal entrapment, resulting in suppressed tumor growth and enhanced anti-cancer activity.
Intra-arterial tenecteplase significantly reduces the risk of symptomatic intracranial hemorrhage and mortality in patients with acute large vessel occlusion. The treatment also improves neurological outcomes at 90 days without increasing complications.
Recent advances in precision medicine for breast cancer have shown significant progress for each subtype, including HR+/HER2- and HER2-positive breast cancers. Immunotherapy has improved pathological complete response rates and survival for triple-negative breast cancer.
Researchers found that smartphone sensors can detect major forms of psychopathology. The study's results may lead to the development of symptom monitoring tools to fill gaps in current practice.
A new study found that targeted concussion treatment improved the quality of life for patients, with 83% reporting full recovery and normal HRQoL scores. The study also revealed that previous concussions were not associated with current poor quality of life scores.
A recent study in the Netherlands found 15% of men who have sex with men and transgender individuals recently used doxycycline as post- or pre-exposure prophylaxis (PrEP), highlighting an increase in informal use. The high intention to use PrEP among the population raises concerns about potential antimicrobial resistance (AMR) and chan...
A new review recommends combining enfortumab vedotin with pembrolizumab as the first-line therapy for advanced urothelial cancer, offering a more effective and better-tolerated alternative to traditional chemotherapy.
A cross-sectional study revealed racial disparities in COVID-19 treatment, with targeted interventions like expanding rapid test access and virtual care potentially improving equity. The findings suggest that encounter-level factors, such as differences in diagnostic test type and site of care, contribute to these inequities.
Researchers aim to replenish the heart's energy reserves by increasing mitochondrial biogenesis, potentially leading to improved recovery rates and longer lives after a heart attack. The project combines synthetic biology tools with animal models and human heart tissue testing.
Scientists from Pusan National University discovered a genetic biomarker, FCGBP, that is strongly linked to bronchiolitis obliterans syndrome and poor outcomes following lung transplantation. The finding may help identify high-risk patients and devise timely immunosuppressive treatments.
A new study reveals persistent inequalities in children's access to life-saving kidney transplants across the UK. Early disparities in ethnicity, socioeconomic status, and gender persist even after being placed on the waitlist.
A study by Carnegie Mellon University researchers found that the closures resulted in a 4% reduction in physicians per capita and declines in infant, non-infant, and total mortality rates. The Flexner Report era reforms led to significant changes in the US medical education landscape.
A new study found that extending Medicaid coverage for 12 months after birth improved access to medical and behavioral health services. This expansion may help mitigate adverse outcomes, including chronic condition management.
The American College of Chest Physicians (CHEST) has launched a critical care APP education and certification program, covering 11 topic areas including patient-centered care and pharmacology. The CCAPP Certification Exam is now available, with an August 5 deadline to apply for the 2025 exam.
UVA Health received two anonymous $25 million estate gifts to support the Paul and Diane Manning Institute of Biotechnology. The institute will develop new treatments for hard-to-treat diseases with a state-of-the-art biomedical research facility expected to drive economic growth in Central Virginia.
Most opioid treatment programs still do not offer all three forms of medication-assisted treatment (MAT) as of 2023. Government-operated programs and those accepting Medicare are more likely to provide comprehensive MAT offerings.
A new approach enables hospital pharmacists to rapidly create bespoke medicine cartridges for rare disease patients, boosting access to personalized treatment. The NANOSPRESSO platform could open up treatments for underfunded and underserved rare conditions worldwide.
Researchers developed a multispectral terahertz optoacoustic system to measure blood sodium levels in real time, non-invasively and accurately. The system overcomes challenges of detecting molecules and penetrating tissue layers using optoacoustic detection.
A new gene therapy delivery device called NANOSPRESSO could revolutionize how hospitals treat rare diseases by allowing them to create personalized nanomedicines in-house. This democratized approach to precision medicine could boost access to low-cost bespoke gene and RNA therapies, especially in low-resource settings.
A study published in The Lancet Global Health found serious quality defects in a significant number of cancer medications from sub-Saharan Africa. Researchers evaluated 251 samples and discovered that one in six medications contained the incorrect quantity of active pharmaceutical ingredient, posing patient safety risks.
A dual-protective approach using Botox and an anti-nausea patch significantly reduces salivary gland toxicity in prostate cancer patients undergoing PSMA-targeted radiopharmaceutical therapy. This strategy led to a 30% decrease in PSMA uptake by the salivary glands without affecting the treatment's cancer-fighting efficacy.
The new NCCN Guidelines Navigator tool offers an interactive platform for accessing evidence-based guidelines, facilitating easier searching and navigation. The initiative aims to improve patient care and outcomes by providing healthcare professionals with up-to-date recommendations.
Researchers at the University of Pennsylvania School of Engineering and Applied Science have turned a deadly fungus into a potent cancer-fighting compound. The new compound, called asperigimycins, has shown promising results against leukemia cells, rivaling FDA-approved drugs.
A new risk calculator, Clue Post-Surgery VTE Risk Instrument, has been developed to reduce unnecessary overtreatment and undertreatment of postoperative venous thromboembolism and bleeding risks. The tool uses just four inputs and provides evidence-based decisions for clinicians and patients.
Researchers at University of Cologne have discovered a previously unknown mechanism that explains why many patients with aggressive B-cell lymphoma don't respond to CAR-T cell therapy. Combining this innovative treatment with CSF1R inhibitors improves its effectiveness, according to the study published in Cancer Cell.
Researchers developed a novel amine-functionalized graphene oxide (NGO) membrane reactor for ultrafast synthesis of propranolol, achieving nearly 100% conversion and selectivity in under 4.63 seconds at 23°C. The NGO membrane exhibited higher catalytic flux and turnover frequency compared to the acidic graphene oxide (GO) membrane.
Physicians from Ruhr-University Bochum used CAR T-cell therapy to treat two patients with chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disease causing paralysis and loss of sensation. The treatment showed rapid and long-lasting effects, with significant improvements in symptoms and functional abilities.
A meta-analysis of over 10,000 patients found that knee braces, hydrotherapy, and exercise are the most effective non-drug therapies for reducing pain and improving mobility in knee osteoarthritis. These treatments offer a safer alternative to anti-inflammatory drugs with fewer gastrointestinal and cardiovascular risks.
A new international study identified two distinct genetic signatures for complex forms of Alzheimer's disease, with one primarily driven by apolipoprotein E and the other involving a combination of 75 additional genetic variants. This shared biological mechanism is largely consistent across global populations.
Researchers at MD Anderson have made significant progress in treating non-small cell lung cancer (NSCLC) by combining chemotherapy, immunotherapy, and surgery. They found that pre-surgical combination therapy showed promising results, with high rates of pathological complete response and major pathological response.
The BathMat clinical trial evaluates an innovative inflatable pillow designed to make moving intensive care unit patients safer, faster, and less labour-intensive for NHS staff. The trials aim to reduce staff time required for repositioning proned patients and improve patient healthcare outcomes.
A team of scientists from Colorado State University and the University of São Paulo have developed a seismological solution to improve the resolution of ultrasound images for lung monitoring. This breakthrough could lead to improved critical care for patients, including continuous lung monitoring at the bedside. The technique uses seis...
A Cleveland Clinic study found that patients taking injectable GLP-1 medications for obesity lost an average of 3.6% body weight, significantly lower than the 11.9% seen in non-discontinuers. Treatment discontinuation negatively impacted blood sugar control in those with prediabetes.